These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 24832775)
1. Use of cysteine-reactive cross-linkers to probe conformational flexibility of human DJ-1 demonstrates that Glu18 mutations are dimers. Prahlad J; Hauser DN; Milkovic NM; Cookson MR; Wilson MA J Neurochem; 2014 Sep; 130(6):839-53. PubMed ID: 24832775 [TBL] [Abstract][Full Text] [Related]
2. Formation of a stabilized cysteine sulfinic acid is critical for the mitochondrial function of the parkinsonism protein DJ-1. Blackinton J; Lakshminarasimhan M; Thomas KJ; Ahmad R; Greggio E; Raza AS; Cookson MR; Wilson MA J Biol Chem; 2009 Mar; 284(10):6476-85. PubMed ID: 19124468 [TBL] [Abstract][Full Text] [Related]
3. Conservation of oxidative protein stabilization in an insect homologue of parkinsonism-associated protein DJ-1. Lin J; Prahlad J; Wilson MA Biochemistry; 2012 May; 51(18):3799-807. PubMed ID: 22515803 [TBL] [Abstract][Full Text] [Related]
4. Roles of distinct cysteine residues in S-nitrosylation and dimerization of DJ-1. Ito G; Ariga H; Nakagawa Y; Iwatsubo T Biochem Biophys Res Commun; 2006 Jan; 339(2):667-72. PubMed ID: 16316629 [TBL] [Abstract][Full Text] [Related]
5. Effect of single amino acid substitution on oxidative modifications of the Parkinson's disease-related protein, DJ-1. Madian AG; Hindupur J; Hulleman JD; Diaz-Maldonado N; Mishra VR; Guigard E; Kay CM; Rochet JC; Regnier FE Mol Cell Proteomics; 2012 Feb; 11(2):M111.010892. PubMed ID: 22104028 [TBL] [Abstract][Full Text] [Related]
6. Cysteine pKa depression by a protonated glutamic acid in human DJ-1. Witt AC; Lakshminarasimhan M; Remington BC; Hasim S; Pozharski E; Wilson MA Biochemistry; 2008 Jul; 47(28):7430-40. PubMed ID: 18570440 [TBL] [Abstract][Full Text] [Related]
7. The role of cysteine oxidation in DJ-1 function and dysfunction. Wilson MA Antioxid Redox Signal; 2011 Jul; 15(1):111-22. PubMed ID: 20812780 [TBL] [Abstract][Full Text] [Related]
8. Identification of an artificial peptide motif that binds and stabilizes reduced human DJ-1. Premkumar L; Dobaczewska MK; Riedl SJ J Struct Biol; 2011 Dec; 176(3):414-8. PubMed ID: 21893204 [TBL] [Abstract][Full Text] [Related]
9. Destabilization of DJ-1 by familial substitution and oxidative modifications: implications for Parkinson's disease. Hulleman JD; Mirzaei H; Guigard E; Taylor KL; Ray SS; Kay CM; Regnier FE; Rochet JC Biochemistry; 2007 May; 46(19):5776-89. PubMed ID: 17451229 [TBL] [Abstract][Full Text] [Related]
10. Structural features of human DJ-1 in distinct Cys106 oxidative states and their relevance to its loss of function in disease. Kiss R; Zhu M; Jójárt B; Czajlik A; Solti K; Fórizs B; Nagy É; Zsila F; Beke-Somfai T; Tóth G Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt A):2619-2629. PubMed ID: 28844983 [TBL] [Abstract][Full Text] [Related]
11. Dopamine-derived quinones affect the structure of the redox sensor DJ-1 through modifications at Cys-106 and Cys-53. Girotto S; Sturlese M; Bellanda M; Tessari I; Cappellini R; Bisaglia M; Bubacco L; Mammi S J Biol Chem; 2012 May; 287(22):18738-49. PubMed ID: 22431735 [TBL] [Abstract][Full Text] [Related]
12. The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Canet-Avilés RM; Wilson MA; Miller DW; Ahmad R; McLendon C; Bandyopadhyay S; Baptista MJ; Ringe D; Petsko GA; Cookson MR Proc Natl Acad Sci U S A; 2004 Jun; 101(24):9103-8. PubMed ID: 15181200 [TBL] [Abstract][Full Text] [Related]
13. Stepwise oxidations play key roles in the structural and functional regulations of DJ-1. Song IK; Kim MS; Ferrell JE; Shin DH; Lee KJ Biochem J; 2021 Oct; 478(19):3505-3525. PubMed ID: 34515295 [TBL] [Abstract][Full Text] [Related]
14. Structural impact of three Parkinsonism-associated missense mutations on human DJ-1. Lakshminarasimhan M; Maldonado MT; Zhou W; Fink AL; Wilson MA Biochemistry; 2008 Feb; 47(5):1381-92. PubMed ID: 18181649 [TBL] [Abstract][Full Text] [Related]
16. Parkinson's disease-associated mutations in DJ-1 modulate its dimerization in living cells. Repici M; Straatman KR; Balduccio N; Enguita FJ; Outeiro TF; Giorgini F J Mol Med (Berl); 2013 May; 91(5):599-611. PubMed ID: 23183826 [TBL] [Abstract][Full Text] [Related]
17. The oxidation state of DJ-1 regulates its chaperone activity toward alpha-synuclein. Zhou W; Zhu M; Wilson MA; Petsko GA; Fink AL J Mol Biol; 2006 Mar; 356(4):1036-48. PubMed ID: 16403519 [TBL] [Abstract][Full Text] [Related]
18. Structure of Cu(I)-bound DJ-1 reveals a biscysteinate metal binding site at the homodimer interface: insights into mutational inactivation of DJ-1 in Parkinsonism. Puno MR; Patel NA; Møller SG; Robinson CV; Moody PC; Odell M J Am Chem Soc; 2013 Oct; 135(43):15974-7. PubMed ID: 24144264 [TBL] [Abstract][Full Text] [Related]
19. Thermodynamic and structural characterization of the specific binding of Zn(II) to human protein DJ-1. Tashiro S; Caaveiro JM; Wu CX; Hoang QQ; Tsumoto K Biochemistry; 2014 Apr; 53(14):2218-20. PubMed ID: 24697266 [TBL] [Abstract][Full Text] [Related]
20. The 1.1-A resolution crystal structure of DJ-1, the protein mutated in autosomal recessive early onset Parkinson's disease. Wilson MA; Collins JL; Hod Y; Ringe D; Petsko GA Proc Natl Acad Sci U S A; 2003 Aug; 100(16):9256-61. PubMed ID: 12855764 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]